Showing results (1-10 of 1,151) with videos related to
Sort By:
Pageof 116
Biochimica Et Biophysica Acta|September 14, 1982
A protein activator of galactosylceramide beta-galactosidaseD A Wenger, M Sattler, S RothMolecular Medicine Today|November 14, 2000
Murine, canine and non-human primate models of Krabbe diseaseD A WengerAPMIS. Supplementum|January 1, 1993
Research update on lysosomal disorders with special emphasis on metachromatic leukodystrophy and Krabbe diseaseD A WengerPediatric Research|May 1, 1983
Biochemical studies in a patient with subacute neuropathic Gaucher disease without visceral glucosylceramide storageD A Wenger, S Roth, T Kudoh, et al.Biochimica Et Biophysica Acta|February 28, 1986
Biosynthesis of the sulfatide/GM1 activator protein (SAP-1) in control and mutant cultured skin fibroblastsS Fujibayashi, D A WengerThe Journal of Clinical Investigation|July 1, 1982
Diagnosis of metachromatic leukodystrophy, Krabbe disease, and Farber disease after uptake of fatty acid-labeled cerebroside sulfate into cultured skin fibroblastsT Kudoh, D A WengerClinical Genetics|October 1, 1984
Usefulness of 4-methylumbelliferyl-6-sulfo-2-acetamido-2-deoxy-beta-D-glucopyrano sid e for the diagnosis of GM2 gangliosidoses in leukocytesK Inui, D A WengerThe Journal of Clinical Investigation|November 1, 1983
Concentrations of an activator protein for sphingolipid hydrolysis in liver and brain samples from patients with lysosomal storage diseasesK Inui, D A WengerThe Journal of Biological Chemistry|November 15, 1986
Synthesis and processing of sphingolipid activator protein-2 (SAP-2) in cultured human fibroblastsS Fujibayashi, D A WengerArchives of Biochemistry and Biophysics|September 1, 1984
Biochemical, immunological, and structural studies on a sphingolipid activator protein (SAP-1)K Inui, D A WengerPageof 116